Briefing: Federal Government Response to COVID-19

March 23, 2020

Please join Gibson Dunn for a discussion of the recently announced federal government responses to the Coronavirus (COVID-19) pandemic.

Topics to be discussed include:

  • Congressional responses
    • Emergency appropriations
    • Family relief (paid sick leave requirements)
    • Stimulus (including President’s proposal)
  • Executive branch relief for businesses and families
    • Emergency declaration
    • SBA loans
    • Tax filing relief
    • Regulatory relief (other than below)
  • Federal Reserve liquidity measures and banking agency actions
  • CFTC actions
  • FDA actions
  • Defense Production Act invocation

Monday, March 23, 2020
1:00 pm – 2:00 pm EDT

View Slides (PDF)
Listen to Audio (MP3) – Audio file is available for download and replay at your convenience


Michael BoppPartner and Co-Chair, Gibson Dunn’s Public Policy Group


Roscoe Jones, Jr.Counsel, former Chief of Staff in House of Representatives and Legislative Director in the U.S. Senate

Marian J. LeePartner, Co-Chair of Gibson Dunn’s global FDA & Health Care Practice

Kristen C. Limarzi, Partner, former Chief of the Appellate Section of the DOJ’s Antitrust Division

Arthur LongPartner, Co-Chair of Gibson Dunn’s Financial Institutions Practice

Amanda C. MachinSenior Associate, Labor & Employment Practice

Lindsay M. PaulinSenior Associate, Government Contracts Practice

Jeffrey L. SteinerPartner, Co-Chair of Gibson Dunn’s Derivatives Practice

Joseph D. WestPartner, former Co-Chair of Gibson Dunn’s Government Contracts Practice